Correlation Between Puma Biotechnology and Vera Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and Vera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and Vera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Puma Biotechnology and Vera Therapeutics, you can compare the effects of market volatilities on Puma Biotechnology and Vera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of Vera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and Vera Therapeutics.

Diversification Opportunities for Puma Biotechnology and Vera Therapeutics

0.1
  Correlation Coefficient

Average diversification

The 3 months correlation between Puma and Vera is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and Vera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vera Therapeutics and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with Vera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vera Therapeutics has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and Vera Therapeutics go up and down completely randomly.

Pair Corralation between Puma Biotechnology and Vera Therapeutics

Given the investment horizon of 90 days Puma Biotechnology is expected to generate 1.79 times more return on investment than Vera Therapeutics. However, Puma Biotechnology is 1.79 times more volatile than Vera Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Vera Therapeutics is currently generating about -0.34 per unit of risk. If you would invest  278.00  in Puma Biotechnology on October 20, 2024 and sell it today you would earn a total of  19.00  from holding Puma Biotechnology or generate 6.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.0%
ValuesDaily Returns

Puma Biotechnology  vs.  Vera Therapeutics

 Performance 
       Timeline  
Puma Biotechnology 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Puma Biotechnology are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Puma Biotechnology demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Vera Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vera Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Puma Biotechnology and Vera Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Puma Biotechnology and Vera Therapeutics

The main advantage of trading using opposite Puma Biotechnology and Vera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, Vera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vera Therapeutics will offset losses from the drop in Vera Therapeutics' long position.
The idea behind Puma Biotechnology and Vera Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Technical Analysis
Check basic technical indicators and analysis based on most latest market data